Funding Opportunities / RFPs

Currently Available Funding Opportunities / Requests for Proposals (RFPs):

COMING SOON: Clinical Trials to Validate AI-Driven Drug Repurposing: This RFP will select at least 6 trials by early 2026. Submission window opens Spring 2025 with LOIs due late Summer 2025. Eligibility / Details: submission must include AI model prediction data as critical pre-clinical support; investigator-initiated, Phase I/IIA clinical trials in any disease area; led by a PI from a nonprofit academic or research institution based anywhere in the world; using already approved drugs, biologics and eligible cellular/gene therapies; and budget: up to $100,000, including a 10% institutional match. Contact research@cureswithinreach.org with questions.

 

ReGRoW: Funding for Underresourced Researchers in Low and Lower-Middle Income Countries 2025: accepting budgets of up to $65,000 for clinical repurposing trials in any disease led by an underresourced researcher in any LMIC, as defined by the World Bank. SUBMISSIONS DUE MARCH 28, 2025.

CureAccelerator
APPLY FOR FUNDING:

If you’re already a ProposalCentral userlog into our new site from the top right corner.

If you don’t have a ProposalCentral login, create a login here.

Learn More About What Stages of Research CWR Funds ↙️

click photo above to enlarge

 

Closed Funding Opportunities / Requests for Proposals (RFPs):

2024

US Based Repurposing Clinical Trials to Address Health Equity 2024: INVITE ONLY accepting budgets of up to $75,000 for repurposing clinical trials to address health equity, including repurposing clinical trials that EITHER are 1) led by an underrepresented researcher OR 2) address health disparities among underrepresented patients OR 3) both 1) and 2). 

Impacting Blood Cancers through Clinical Repurposing Trials 2024: accepting budgets of up to $75,000 from institutions worldwide for clinical repurposing trials targeting any blood cancer, with a preference for trials impacting multiple myeloma and/or myelodysplastic syndromes. 

ReGRoW: Funding for Underresourced Researchers in Low and Lower-Middle Income Countries 2024: accepting budgets of up to $65,000 for clinical repurposing trials in any disease led by an underresourced researcher in any LMIC, as defined by the World Bank

Clinical Repurposing Research to Impact Veterans/Military 2024: accepting budgets of up to $75,000 to a U.S.-based institution for a repurposing clinical trial in any disease area impacting veterans or active military, such as mental health, PTSD and brain injuries. 

Repurposing Research for Chicago 2024: accepting budgets of up to $100,000 for clinical repurposing trials from Chicago area research institutions in one or more of the following tracks. 

2023

2022

2021

2020